Subscribe Sign In Register

Abbvie

Portfolio
U.S. M&A Could Rebound as Companies See Few Other Growth Options
Dan Weil
July 6, 2016
2016-04-da-haruhiko-kuroda-large.jpg
Portfolio
Daily Agenda: Markets Surprised as Bank of Japan Holds Firm
Andrew Barber
April 28, 2016
2016-03-vitaliy-katsenelson-gilead-sciences-lab-worker-large.jpg
Portfolio
Gilead Sciences’ Miracle Drug Combination
Vitaliy Katsenelson
February 23, 2016
Portfolio
AbbVie Enters the Battle of the Biosimilars
Khadijah M Silver
January 15, 2016
2015-12-kaitlin-ugolik-healthcare-large.jpg
Corner Office
Investing in the Health Care Revolution
Kaitlin Ugolik
January 4, 2016
Inside Gilead Sciences Inc.
Portfolio
Specialty Pharma Drugs Raise Difficult Issues
Khadijah M Silver
December 15, 2015
Sex-for-Life Testosterone Boost Fueling Safety Concerns: Health
Portfolio
Aggressive Pharma Ads Yield Results — and Complaints
Khadijah M Silver
December 4, 2015
2014-10-da-mohawk-iphone-large.jpg
Portfolio
Daily Agenda: What, If Anything, Has Changed in the Economy?
Andrew Barber
October 20, 2014
CNBC Events - Season 2014
Corner Office
To Combat Inversions, It May Be Time to Raise Some Taxes
Aaron Timms
July 24, 2014